The PennZone

  • Home
  • Non-profit
  • Education
  • Technology
  • Construction
  • Business
  • Marketing
  • Entertainment
  • Health

Techdow USA Announces FDA Approval of Generic Lovenox®, (Enoxaparin Sodium – Preservative Free) In Prefilled Syringes
The PennZone/10224695

Trending...
  • Proper Sky Named to the 2026 MSP 501
  • Slotozilla Introduces a Centralized Resource for World Cup Bonus Offers
  • 100+ Episodes In, Liftoff with Keith Newman Tells Founders to Stop Publishing More
LANGHORNE, Pa. ~ Techdow USA Inc., a vertically integrated generic injectables company, has announced the FDA approval of Enoxaparin Sodium (Preservative Free) in Prefilled Syringes for the U.S. market.

Darren Alkins, Chief Executive Officer of Techdow USA, said "We are excited to bring this critical product to institutions, retail and other networks in need of a safe, affordable and reliable source of Enoxaparin. Our U.S. and global networks will help ensure reliable Enoxaparin supply, while offering competitive pricing."

The launch of Enoxaparin will compliment Techdow USA's existing Heparin Sodium injection business which was launched in 2022. According to IQVIA Health for the 12 months ending December 2022, Enoxaparin Sodium (Preservative Free) Prefilled Syringes had US brand and generic sales of approximately $550 million.

Techdow USA is among the fastest growing companies in the US generic pharmaceutical industry specializing in the sale of generic injectable pharmaceuticals and continues to work to expand their product portfolio and pipeline to better serve patient and customer needs. To report SUSPECTED ADVERSE REACTIONS, contact Hepalink USA, Inc./Techdow USA, Inc. at 1-888-355-1375 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For more information visit www.techdowusa.com.*Lovenox® is a registered trademark of Sanofi-Aventis U.S. LLC

More on The PennZone
  • J&J Exterminating Mourns the Passing of Founder Bobby John Sr
  • Delirious Comedy Club Transforms Into Las Vegas' Newest Live Comedy Studio With Weekly Delirious TV Tapings
  • BitTitan Advances MigrationWiz with New Capabilities, Platform Enhancements, and Product Leadership Update
  • Sara Abbas Receives "Eniochos" Charioteer Award at 2026 Who is Who International Awards
  • Detained at 95: South Korea's Prosecution of a Religious Leader Draws International Alarm

Techdow USA Inc., a growing market leader in the generic injectables industry, has announced that its product Enoxaparin Sodium (Preservative Free) in Prefilled Syringes has been approved by the FDA for use in the U.S market. Darren Alkins, Chief Executive Officer of Techdow USA expressed his excitement about bringing this critical product to institutions, retail and other networks that need a safe, affordable and reliable source of Enoxaparin with competitive pricing options available through their U.S and global networks as well as being a long term reliable resource for the marketplace .

The launch of Enoxaparin compliments Techdow USA's existing Heparin Sodium injection business which was launched in 2022 with IQVIA Health reporting US brand and generic sales for this product at approximately $550 million for the 12 months ending December 2022 .

Techdow USA is continuing its efforts to expand its product portfolio and pipeline to better serve patient and customer needs while also being one of the fastest growing companies in the US generic pharmaceutical industry specializing in selling generic injectable pharmaceuticals . To report SUSPECTED ADVERSE REACTIONS contact Hepalink USA , Inc./Techdow USA , Inc . at 1 - 888 - 355 - 1375 or FDA at 1 - 800 - FDA - 1088 or www . fda . gov / medwatch . For more information visit www . techdowusa . com * Lovenox® is a registered trademark of Sanofi - Aventis U . S . LLC
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • PropAccount.com Adds Prediction Markets to Its Multi-Asset Prop Firm Platform
  • ToyLookup.com Launches AI-Powered Platform to Help Collectors Identify Vintage and Modern Toys
  • Rising star Hip-Hop and R&B Force Della Drops Highly Anticipated New Single, "Throw It"
  • UK Financial Ltd. Opens Test-Phase Maya 3 Liquidity Pool on Uniswap with DEX Screener Visibility for Market-Smoothing Ahead of CATEX Exchange Launch
  • From DECA Finalist to Translational Scientist: Roohid Parast on Business Training in Biopharma
  • Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers
  • June Employment Report Reveals Hidden Weakness Beneath Lower Unemployment
  • Exeter Smiles Encourages Families to Start Teen Braces This Summer
  • The Hue Society Expands Roster for the 2026 Wine and Culture Fest
  • Kasinohai Audit: Most Slots Could Be Affected by Finland's Draft Gambling Rules
  • Why More Phoenix Families Are Turning to Private Autopsy Services for Answers
  • Fig Lehigh Valley Celebrates 50th Edition With Summer Launch Party at the Americus Hotel
  • Make America French Again Launches National Campaign
  • RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project
  • New Children's Book Teaches Kids the Lesson Its Author Spent a Career Learning: Your Worth Doesn't Need Permission
  • Proper Sky Named to the 2026 MSP 501
  • 100+ Episodes In, Liftoff with Keith Newman Tells Founders to Stop Publishing More
  • Vierra Communities Adds Operations of Two Skilled Nursing Facilities in the DC Metro Area
  • Slotozilla Introduces a Centralized Resource for World Cup Bonus Offers
  • Webinar Announcement: Built for Trust: Latitude's 0 to 1 Compliance Playbook for Modern Cross-Border Payments

Popular on PennZone

  • Kevin Francis Design Introduces CHROMA, a Collection of Saturated Solid Color Wool Rugs - 275
  • Bergey's Truck Centers Recognized in 2026 MACH Alliance Composable Impact Awards
  • $150+ Million Contracted Backlog, Strategic Acquisitions Adding Millions In Recurring Revenue, Improving Margins & A Clear Path Toward Profitability
  • Super Lawyers Recognizes Inman & Tourgee Attorneys Mark Tourgee and Jacob Rinn
  • ReviewsAlly Launches Evidence-Based Review Platform for VPNs, Business Software, and Online Services
  • New Luxury Single Family Homes From $976,990 in Manalapan
  • What Would you Do with Your Time if it Was Actually Money?
  • Expanding Access to Mental Health Care in Toronto with Dr. Stephen Shainbart
  • Hosted Network Powers National Growth with netElastic vBNG, CGNAT and netVision
  • Appliance EMT Launches June "Summer Rescue" Promotion

Similar on PennZone

  • David Pedrol named Managing Director in Indonesia
  • AutomationIQ Launches to Bring Enterprise-Grade AI Automation to Local and Mid-Market Businesses
  • Discard Junk Removal Named #1 Junk Removal Company in Sacramento Out of 189 Businesses Evaluated
  • J&J Exterminating Mourns the Passing of Founder Bobby John Sr
  • Sara Abbas Receives "Eniochos" Charioteer Award at 2026 Who is Who International Awards
  • PropAccount.com Adds Prediction Markets to Its Multi-Asset Prop Firm Platform
  • UK Financial Ltd. Opens Test-Phase Maya 3 Liquidity Pool on Uniswap with DEX Screener Visibility for Market-Smoothing Ahead of CATEX Exchange Launch
  • Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers
  • June Employment Report Reveals Hidden Weakness Beneath Lower Unemployment
  • Kasinohai Audit: Most Slots Could Be Affected by Finland's Draft Gambling Rules
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us